5 questions most teams skip before deploying AI

A new feature fails quietly. A bad AI interaction in the wrong market, with the wrong user, in the wrong cultural context, doesn’t. It gets shared. It gets screenshotted. It becomes the story about your product that you didn’t write.

Most teams know this in theory. In practice, the pressure to ship fast means certain questions get skipped, not because teams are reckless, but because there isn’t always a simple way of answering them. The benchmark scores are good. The automated and internal testing is done. But you are still missing vital information that is critical to launch, and the date is locked.

These are the five questions worth pausing on before you go.

1. Do You Know How Your Product Behaves Across Different User Contexts?

Most GenAI products are built by teams in one market, trained predominantly on data from a handful of others, and tested by people who look nothing like the full range of users who will actually interact with the product.

The Gap Between Build and Reality

This isn’t a flaw in the model. It’s a gap between the environment where the product was built and the environment where it will be used. Different languages carry different connotations. Different cultures have different expectations of what a helpful, trustworthy response looks like. Different markets have different thresholds for what feels appropriate.

What This Looks Like in Practice

One product team we spoke to saw this play out when launching a customer support assistant across multiple European markets. Internally, everything looked strong. But in-market feedback told a different story. In one country, users described the assistant as helpful. In another, the exact same responses were perceived as cold and patronising.

2. What Does “Safe” Mean in Each Market You’re Entering?

Safety in AI is not a universal standard. What is considered a responsible response in one cultural context can be tone-deaf, offensive, or simply wrong in another.

Why Safety Is Contextual

Topics that are neutral in one market are sensitive in another. Levels of directness that feel helpful in one context feel aggressive in another.

The Risk of One-Size-Fits-All Definitions

Most teams define “safe” once, internally, early in the build process, and don’t revisit it when the scope expands to new markets. That definition is almost always shaped by the background and experience of the team that wrote it, which is rarely representative of every market the product is about to enter.

Why Assumptions Are Not Enough

We’ve seen cases where a model’s responses around financial advice were considered appropriately cautious in one market, but overly vague and unhelpful in another where users expected clearer guidance. In other instances, topics treated as neutral in training and internal evaluation triggered sensitivity in specific regions due to cultural or political context.

Before you deploy, it is worth asking who was in the room when your safety criteria were defined, and whether those criteria have been tested against the actual expectations of users in each target market. A safety standard that has never been stress-tested by real people in the markets it applies to is not really a safety standard. It is an assumption.

3. If a Regulator Asked How You Evaluated This Product, What Would You Say?

This question is becoming less hypothetical by the month.

Regulation Is Catching Up Fast

The EU AI Act, which came into force in August 2024 and is now progressively applying obligations across different risk categories, already requires companies to demonstrate how they evaluated AI systems before deployment. Regulators in the UK, and increasingly in Asia and Latin America, are developing their own frameworks along similar lines.

Why Old Answers No Longer Hold

The honest answer for many teams right now is: we ran automated tests, the scores were within an acceptable range, and we shipped. That answer may have been fine eighteen months ago. It is becoming less defensible.

What Strong Evidence Looks Like

The more useful question is not whether you will face regulatory scrutiny, but whether you have the kind of evidence that would hold up if you did. Structured evaluation findings, documented methodology, evidence of human review across the markets you’re operating in: these are the things that turn a regulatory conversation from a liability into a demonstration of due diligence.

Building that evidence is not primarily a legal exercise. It is a product discipline. The teams that do it well are also the teams that ship with more confidence, because they have answered the hard questions before someone else asks them.

4. What Happens When It Fails, and Who Finds Out First?

Every AI product will produce a response at some point that it shouldn’t. The question is not whether this will happen. It’s whether you find out through your own monitoring or through a user posting about it publicly.

The Visibility Gap Across Markets

Most teams have some version of a feedback loop, a way to flag bad outputs, a process for reviewing edge cases. The gap is usually in the markets that weren’t central to the initial build. Monitoring tends to be strongest where the team has the most context and weakest where they have the least.

Why Detection Speed Matters

In more than one case, teams have only become aware of an issue once it surfaced externally, through user complaints or social posts in a local market. Internally, nothing had triggered alerts. The failure wasn’t just the output itself, but the delay in recognising it. By the time it was addressed, the narrative had already formed.

Before you deploy in a new market, it is worth mapping out what your failure detection looks like specifically for that market. Who is reviewing flagged outputs? Do they have the cultural context to recognise a problem that wouldn’t be visible to a native English speaker in San Francisco? How quickly can you act if something surfaces? The speed of your response to a failure often matters as much as the failure itself.

5. Does Your Evaluation Evidence Travel?

This is the question that separates teams that are genuinely ready from teams that feel ready.

Why Internal Confidence Isn’t Enough

Internal confidence is not transferable. If the answer to “how do we know this is ready?” is “we’ve been working on this for eight months, and we know the product well,” that answer works in a room full of people who have been on the journey with you. It does not work with a new market lead who needs to explain the product to local partners. It does not work with a legal team reviewing deployment risk. It does not work with a board that is reading about AI failures in the news and asking pointed questions.

What Transferable Evidence Looks Like

Evidence travels. A structured evaluation report, findings from real users in real markets, documented decisions about identified risks: these are the things that let everyone in the organisation, not just the product team, speak with confidence about the product’s readiness.

Why This Protects Your Team

They are also the things that protect the team if something goes wrong, because they demonstrate that the right questions were asked and the right process was followed before the product shipped.

Why These Questions Matter Before You Launch

Most of these questions don’t have simple answers. That’s the point. They are the questions worth sitting with before the launch date makes them harder to ask.

How Can GAT AI GroundTruth Help?

If you’re deploying a GenAI product in a new market and want to understand what structured real-world human evaluation looks like in practice, the GAT AI GroundTruth team is available for a conversation.

Source: For the full text of the EU AI Act: artificialintelligenceact.eu